vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $151.1M, roughly 1.4× STURM RUGER & CO INC). On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 3.6%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $12.3M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 5.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
COLL vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $151.1M |
| Net Profit | $17.0M | — |
| Gross Margin | 62.5% | 17.8% |
| Operating Margin | 29.6% | 2.3% |
| Net Margin | 8.3% | — |
| Revenue YoY | 12.9% | 3.6% |
| Net Profit YoY | 35.3% | — |
| EPS (diluted) | $0.48 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $151.1M | ||
| Q3 25 | $209.4M | $126.8M | ||
| Q2 25 | $188.0M | $132.5M | ||
| Q1 25 | $177.8M | $135.7M | ||
| Q4 24 | $181.9M | $145.8M | ||
| Q3 24 | $159.3M | $122.3M | ||
| Q2 24 | $145.3M | $130.8M | ||
| Q1 24 | $144.9M | $136.8M |
| Q4 25 | $17.0M | — | ||
| Q3 25 | $31.5M | $1.6M | ||
| Q2 25 | $12.0M | $-17.2M | ||
| Q1 25 | $2.4M | $7.8M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $9.3M | $4.7M | ||
| Q2 24 | $19.6M | $8.3M | ||
| Q1 24 | $27.7M | $7.1M |
| Q4 25 | 62.5% | 17.8% | ||
| Q3 25 | 61.7% | 15.1% | ||
| Q2 25 | 57.7% | 3.9% | ||
| Q1 25 | 54.8% | 22.0% | ||
| Q4 24 | 54.0% | 22.8% | ||
| Q3 24 | 60.8% | 18.5% | ||
| Q2 24 | 62.5% | 22.3% | ||
| Q1 24 | 63.1% | 21.5% |
| Q4 25 | 29.6% | 2.3% | ||
| Q3 25 | 29.7% | -2.7% | ||
| Q2 25 | 18.7% | -15.6% | ||
| Q1 25 | 12.2% | 6.2% | ||
| Q4 24 | 20.9% | 7.8% | ||
| Q3 24 | 21.9% | 3.1% | ||
| Q2 24 | 32.7% | 6.9% | ||
| Q1 24 | 34.1% | 5.5% |
| Q4 25 | 8.3% | — | ||
| Q3 25 | 15.0% | 1.2% | ||
| Q2 25 | 6.4% | -13.0% | ||
| Q1 25 | 1.4% | 5.7% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 5.9% | 3.9% | ||
| Q2 24 | 13.5% | 6.3% | ||
| Q1 24 | 19.1% | 5.2% |
| Q4 25 | $0.48 | $0.22 | ||
| Q3 25 | $0.84 | $0.10 | ||
| Q2 25 | $0.34 | $-1.05 | ||
| Q1 25 | $0.07 | $0.46 | ||
| Q4 24 | $0.36 | $0.62 | ||
| Q3 24 | $0.27 | $0.28 | ||
| Q2 24 | $0.52 | $0.47 | ||
| Q1 24 | $0.71 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $92.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $283.8M |
| Total Assets | $1.7B | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $92.5M | ||
| Q3 25 | $285.9M | $80.8M | ||
| Q2 25 | $222.2M | $101.4M | ||
| Q1 25 | $197.8M | $108.3M | ||
| Q4 24 | $162.8M | $105.5M | ||
| Q3 24 | $120.0M | $96.0M | ||
| Q2 24 | $271.6M | $105.6M | ||
| Q1 24 | $318.0M | $115.3M |
| Q4 25 | $301.7M | $283.8M | ||
| Q3 25 | $274.8M | $279.6M | ||
| Q2 25 | $232.2M | $289.3M | ||
| Q1 25 | $234.4M | $321.5M | ||
| Q4 24 | $228.8M | $319.6M | ||
| Q3 24 | $234.3M | $314.9M | ||
| Q2 24 | $216.6M | $321.5M | ||
| Q1 24 | $222.2M | $332.0M |
| Q4 25 | $1.7B | $342.0M | ||
| Q3 25 | $1.6B | $342.3M | ||
| Q2 25 | $1.6B | $349.5M | ||
| Q1 25 | $1.6B | $379.0M | ||
| Q4 24 | $1.7B | $384.0M | ||
| Q3 24 | $1.6B | $373.5M | ||
| Q2 24 | $1.1B | $376.7M | ||
| Q1 24 | $1.1B | $385.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $15.5M |
| Free Cash FlowOCF − Capex | $122.4M | $12.3M |
| FCF MarginFCF / Revenue | 59.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.3% | 2.1% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $15.5M | ||
| Q3 25 | $78.4M | $12.9M | ||
| Q2 25 | $72.4M | $14.7M | ||
| Q1 25 | $55.4M | $11.1M | ||
| Q4 24 | $84.6M | $20.0M | ||
| Q3 24 | $-9.0M | $9.4M | ||
| Q2 24 | $67.4M | $18.7M | ||
| Q1 24 | $61.9M | $7.3M |
| Q4 25 | $122.4M | $12.3M | ||
| Q3 25 | $78.3M | $7.0M | ||
| Q2 25 | $72.4M | $9.1M | ||
| Q1 25 | $54.6M | $10.0M | ||
| Q4 24 | $84.1M | $16.4M | ||
| Q3 24 | $-9.2M | $2.6M | ||
| Q2 24 | $67.1M | $10.1M | ||
| Q1 24 | $61.4M | $5.6M |
| Q4 25 | 59.6% | 8.2% | ||
| Q3 25 | 37.4% | 5.5% | ||
| Q2 25 | 38.5% | 6.9% | ||
| Q1 25 | 30.7% | 7.4% | ||
| Q4 24 | 46.2% | 11.2% | ||
| Q3 24 | -5.8% | 2.1% | ||
| Q2 24 | 46.2% | 7.7% | ||
| Q1 24 | 42.3% | 4.1% |
| Q4 25 | 0.3% | 2.1% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | 0.0% | 4.2% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.3% | 2.5% | ||
| Q3 24 | 0.2% | 5.5% | ||
| Q2 24 | 0.2% | 6.6% | ||
| Q1 24 | 0.4% | 1.3% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 8.15× | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | 1.43× | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 1.98× | ||
| Q2 24 | 3.44× | 2.27× | ||
| Q1 24 | 2.23× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
